FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Cartilage / Telomerase Activity in Articular Chondrocytes Is Lost after ...
Cartilage2015; 5(4); 215-220; doi: 10.1177/1947603514537518

Telomerase Activity in Articular Chondrocytes Is Lost after Puberty.

Abstract: Telomere length and telomerase activity are important indicators of cellular senescence and replicative ability. Loss of telomerase is associated with ageing and the development of osteoarthritis. Implantation of telomerase-positive cells, chondrocytes, or stem cells expressing a normal chondrocyte phenotype is desired for cartilage repair procedures. The objective of this study was to identify at what age chondrocytes and at what passage bone marrow-derived mesenchymal stem cells (MSCs) become senescent based on telomerase activity. The effect of osteogenic protein-1 (OP-1) or interleukin-1α (IL-1α) treatment on telomerase activity in chondrocytes was also measured to determine the response to anabolic or catabolic stimuli. Methods: Articular cartilage was collected from horses (n = 12) aged 1 month to 18 years. Chondrocytes from prepubescent horses (<15 months) were treated with OP-1 or IL-1α. Bone marrow aspirate from adult horses was collected and cultured for up to 10 days to isolate MSCs. Telomerase activity was measured using the TeloTAGGG Telomerase PCR ELISA kit. Results: Chondrocytes from prepubescent horses were positive for telomerase activity. Treatment with IL-1α resulted in a decrease in chondrocyte telomerase activity; however, treatment with OP-1 did not change telomerase activity. One MSC culture sample was positive for telomerase activity on day 2; all samples were negative for telomerase activity on day 10. Conclusions: These results suggest that chondrocytes from prepubescent donors are potentially more suitable for cartilage repair procedures and that telomerase activity is diminished by anabolic and catabolic cytokine stimulation. If MSCs are utilized in cartilage repair, minimal passaging should be performed prior to implantation.
Get Full Text
Publication Date: 2015-06-13 PubMed ID: 26069700PubMed Central: PMC4335769DOI: 10.1177/1947603514537518Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explores the relationship between ageing and the activity of telomerase in articular chondrocytes (cells found in the cartilage), and its implications for medical treatments such as cartilage repair. The study found that telomerase activity in these cells decreases after puberty, affects their reparative ability, and that minimally-passaged stem cell therapy might be a successful strategy for cartilage repair.

Objective of the Study

  • The primary aim of this study was to understand the telomerase activity in chondrocytes and its potential impact on ageing and the development of conditions like osteoarthritis.
  • This study sought to determine when bone marrow-derived mesenchymal stem cells (MSCs) and chondrocytes become senescent (old and non-functioning) based on telomerase activity.
  • It also aimed to analyze the effect of certain treatments, such as osteogenic protein-1 (OP-1) and interleukin-1α (IL-1α), on the telomerase activity of chondrocytes.

Research Methods

  • The researchers collected articular cartilage from horses. The subjects ranged in age from 1 month to 18 years.
  • Chondrocytes from young horses (less than 15 months old) were treated with OP-1 or IL-1α to study the changes in telomerase activity.
  • Bone marrow from adult horses was also collected, cultured, and examined up to a period of 10 days to isolate mesenchymal stem cells (MSCs).
  • The TeloTAGGG Telomerase PCR ELISA kit was used to measure telomerase activity.

Results

  • Chondrocytes from young (prepubescent) horses showed positive telomerase activity. However, with the treatment of IL-1α, the telomerase activity decreased. OP-1 treatment did not have a significant impact on the telomerase activity of these cells.
  • Detectable telomerase activity was present in one of the MSC cultures on day 2, but by day 10, all of the MSC samples lacked telomerase activity.

Conclusions

  • The study concluded that chondrocytes that exhibit telomerase activity are potentially more suitable for cartilage repair procedures. Therefore, cells extracted from prepubescent donors might be more effective for these treatments.
  • The presence of telomerase activity in MSCs and chondrocytes appears to be affected by both anabolic and catabolic cytokine stimulation. Therefore, if MSCs are to be used in cartilage repair, they should be minimally passaged prior to implantation.

Cite This Article

APA
Wilson B, Novakofski KD, Donocoff RS, Liang YX, Fortier LA. (2015). Telomerase Activity in Articular Chondrocytes Is Lost after Puberty. Cartilage, 5(4), 215-220. https://doi.org/10.1177/1947603514537518

Publication

Cartilage
ISSN: 1947-6035
NlmUniqueID: 101518378
Country: United States
Language: English
Volume: 5
Issue: 4
Pages: 215-220

Researcher Affiliations

Wilson, Brooke
  • Department of Clinical Sciences, Cornell University, Ithaca, NY, USA.
Novakofski, Kira D
  • Department of Clinical Sciences, Cornell University, Ithaca, NY, USA.
Donocoff, Rachel Sacher
  • Department of Clinical Sciences, Cornell University, Ithaca, NY, USA.
Liang, Yan-Xiang Amber
  • Department of Clinical Sciences, Cornell University, Ithaca, NY, USA.
Fortier, Lisa A
  • Department of Clinical Sciences, Cornell University, Ithaca, NY, USA.

Conflict of Interest Statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

This article includes 41 references
  1. Antonelli MC, Starz TW. Assessing for risk and progression of osteoarthritis: the nurse’s role. Am J Nurs 2012;112(3 Suppl 1):S26-31.
    pubmed: 22373743
  2. Shane Anderson A, Loeser RF. Why is osteoarthritis an age-related disease?. Best Pract Res Clin Rheumatol 2010;24(1):15-26.
    pmc: PMC2818253pubmed: 20129196
  3. Martin JA, Buckwalter JA. Telomere erosion and senescence in human articular cartilage chondrocytes. J Gerontol A Biol Sci Med Sci 2001;56(4):B172-9.
    pubmed: 11283188
  4. Zhao Z, Pan X, Liu L, Liu N. Telomere length maintenance, shortening, and lengthening. J Cell Physiol Epub 2013. Dec 20.
    pubmed: 24374808
  5. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345(6274):458-60.
    pubmed: 2342578
  6. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995;220(1):194-200.
    pubmed: 7664836
  7. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 1988;85(18):6622-6.
    pmc: PMC282029pubmed: 3413114
  8. Blackburn EH. Structure and function of telomeres. Nature 1991;350(6319):569-73.
    pubmed: 1708110
  9. Bailey SM, Goodwin EH. DNA and telomeres: beginnings and endings. Cytogenet Genome Res 2004;104(1-4):109-15.
    pubmed: 15162023
  10. Yu GL, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated tetrahymena telomerase RNAs. Nature 1990;344(6262):126-32.
    pubmed: 1689810
  11. Notaro R, Cimmino A, Tabarini D, Rotoli B, Luzzatto L. In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A 1997;94(25):13782-5.
    pmc: PMC28384pubmed: 9391104
  12. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11(5):1921-9.
    pmc: PMC556651pubmed: 1582420
  13. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP. The RNA component of human telomerase. Science 1995;269(5228):1236-41.
    pubmed: 7544491
  14. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB. Telomerase maintains telomere structure in normal human cells. Cell 2003;114(2):241-53.
    pubmed: 12887925
  15. Hiyama E, Hiyama K. Telomere and telomerase in stem cells. Br J Cancer 2007;96(7):1020-4.
    pmc: PMC2360127pubmed: 17353922
  16. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 1995;92(20):9082-6.
    pmc: PMC40928pubmed: 7568077
  17. Parsch D, Fellenberg J, Brummendorf TH, Eschlbeck AM, Richter W. Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J Mol Med (Berl) 2004;82(1):49-55.
    pubmed: 14647922
  18. Greenwood MJ, Lansdorp PM. Telomeres, telomerase, and hematopoietic stem cell biology. Arch Med Res 2003;34(6):489-95.
    pubmed: 14734088
  19. Neri S, Bourin P, Peyrafitte JA, Cattini L, Facchini A, Mariani E. Human adipose stromal cells (ASC) for the regeneration of injured cartilage display genetic stability after in vitro culture expansion. PLoS One 2013;8(10):e77895.
    pmc: PMC3810264pubmed: 24205017
  20. Ryu E, Hong S, Kang J, Woo J, Park J, Lee J, Seo JS. Identification of senescence-associated genes in human bone marrow mesenchymal stem cells. Biochem Biophys Res Commun 2008;371(3):431-6.
    pubmed: 18452712
  21. Li J, Pei M. Cell senescence: a challenge in cartilage engineering and regeneration. Tissue Eng Part B Rev 2012;18(4):270-87.
    pubmed: 22273114
  22. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002;27(7):339-44.
    pubmed: 12114022
  23. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 2004;101(49):17312-5.
    pmc: PMC534658pubmed: 15574496
  24. Martin JA, Klingelhutz AJ, Moussavi-Harami F, Buckwalter JA. Effects of oxidative damage and telomerase activity on human articular cartilage chondrocyte senescence. J Gerontol A Biol Sci Med Sci 2004;59(4):324-37.
    pubmed: 15071075
  25. Martin JA, Buckwalter JA. The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am 2003;85-A Suppl 2:106-10.
    pubmed: 12721352
  26. Chubinskaya S, Kumar B, Merrihew C, Heretis K, Rueger DC, Kuettner KE. Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim Biophys Acta 2002;1588(2):126-34.
    pubmed: 12385776
  27. Chubinskaya S, Otten L, Soeder S, Borgia JA, Aigner T, Rueger DC, Loeser RF. Regulation of chondrocyte gene expression by osteogenic protein-1. Arthritis Res Ther 2011;13(2):R55.
    pmc: PMC3132046pubmed: 21447156
  28. Chubinskaya S, Kuettner KE. Regulation of osteogenic proteins by chondrocytes. Int J Biochem Cell Biol 2003;35(9):1323-40.
    pubmed: 12798347
  29. Flechtenmacher J, Huch K, Thonar EJ, Mollenhauer JA, Davies SR, Schmid TM. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 1996;39:1896-904.
    pubmed: 8912513
  30. Khan IM, Bishop JC, Gilbert S, Archer CW. Clonal chondroprogenitors maintain telomerase activity and Sox9 expression during extended monolayer culture and retain chondrogenic potential. Osteoarthritis Cartilage 2009;17(4):518-28.
    pubmed: 19010695
  31. D’Souza Y, Lauzon C, Chu TW, Autexier C. Regulation of telomere length and homeostasis by telomerase enzyme processivity. J Cell Sci 2013;126(Pt 2):676-87.
    pubmed: 23178942
  32. Nixon AJ, Lust G, Vernier-Singer M. Isolation, propagation and cryopreservation of equine articular chondrocytes. Am J Vet Res 1992;53:2364-70.
    pubmed: 1476323
  33. Fortier LA, Kornatowski MA, Mohammed HO, Jordan MT, O’Cain LC, Stevens WB. Age-related changes in serum insulin-like growth factor-I, insulin-like growth factor-I binding protein-3 and articular cartilage structure in thoroughbred horses. Equine Vet J 2010;37(1):37-42.
    pubmed: 15651732
  34. Loeser RF, Pacione CA, Chubinskaya S. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes. Arthritis Rheum 2003;48(8):2188-96.
    pubmed: 12905472
  35. Chubinskaya S, Segalite D, Pikovsky D, Hakimiyan AA, Rueger DC. Effects induced by BMPS in cultures of human articular chondrocytes: comparative studies. Growth Factors 2008;26(5):275-83.
    pubmed: 18651287
  36. Brandl A, Angele P, Roll C, Prantl L, Kujat R, Kinner B. Influence of the growth factors PDGF-BB, TGF-beta1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion. J Orthop Res 2010;28(3):354-60.
    pubmed: 19798738
  37. Patton GC, Viner R. Pubertal transitions in health. Lancet 2007;369(9567):1130-9.
    pubmed: 17398312
  38. Rufer N, Migliaccio M, Antonchuk J, Humphries RK, Roosnek E, Lansdorp PM. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 2001;98(3):597-603.
    pubmed: 11468156
  39. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002;20(6):592-6.
    pubmed: 12042863
  40. Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther 1998;80(1):35-47.
    pubmed: 9804053
  41. Hu B, Tack DC, Liu T, Wu Z, Ullenbruch MR, Phan SH. Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFbeta. Oncogene 2006;25(7):1030-41.
    pubmed: 16205635
Subscribe to our newsletter
Join 99,034 horse owners like you who receive our email updates on horse health and nutrition.